Tim Dyer
Gründer bei ADDEX THERAPEUTICS LTD
Vermögen: 1 Mio $ am 31.05.2024
Profil
Timothy Dyer is the founder of Addex Therapeutics Ltd.
(founded in 2002) and serves as the Chief Executive Officer & Executive Director.
Mr. Dyer is also the founder of Tmd Advisory SARL.
Currently, Mr. Dyer holds the position of Chief Executive Officer & Director at Neurosterix SA and Director at Qwane Biosciences SA. In the past, Mr. Dyer worked as the Vice Chairman at Abionic SA and as a Principal at PricewaterhouseCoopers International Ltd.
Mr. Dyer completed his undergraduate degree at The University of Southampton.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADDEX THERAPEUTICS LTD
9,14% | 29.02.2024 | 16 848 979 ( 9,14% ) | 1 Mio $ | 31.05.2024 |
Aktive Positionen von Tim Dyer
| Unternehmen | Position | Beginn |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Gründer | 01.01.2002 |
Qwane Biosciences SA
 Qwane Biosciences SA Information Technology ServicesTechnology Services Qwane Biosciences SA is a Swiss company that specializes in providing high precision and high-performance electrophysiology tools for in vitro electrical monitoring of biological samples. Qwane Biosciences is based in Lausanne, CH. The private company's micro electrode array products, which are devices comprising micro-fabricated metal electrodes, are used for in vitro recording and stimulation of electrical activity from neuronal cells & tissue or cardiac tissue. The company is also developing mea-based solutions specifically tailored for applications in drug discovery and safety pharmacology. | Direktor/Vorstandsmitglied | - |
| Tmd Advisory SARL | Gründer | - |
Ehemalige bekannte Positionen von Tim Dyer
| Unternehmen | Position | Ende |
|---|---|---|
PricewaterhouseCoopers International Ltd.
 PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Abionic SA
 Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | - |
Ausbildung von Tim Dyer
| The University of Southampton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADDEX THERAPEUTICS LTD | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Abionic SA
Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Qwane Biosciences SA
Qwane Biosciences SA Information Technology ServicesTechnology Services Qwane Biosciences SA is a Swiss company that specializes in providing high precision and high-performance electrophysiology tools for in vitro electrical monitoring of biological samples. Qwane Biosciences is based in Lausanne, CH. The private company's micro electrode array products, which are devices comprising micro-fabricated metal electrodes, are used for in vitro recording and stimulation of electrical activity from neuronal cells & tissue or cardiac tissue. The company is also developing mea-based solutions specifically tailored for applications in drug discovery and safety pharmacology. | Technology Services |
PricewaterhouseCoopers International Ltd.
PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
| Tmd Advisory SARL |